Related Experiment Video
Updated: Jun 1, 2025

10:51
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
4.1K
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
Qianying Zuo1,2, Yibin Kang3,4
1Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Advances in Experimental Medicine and Biology
|January 17, 2025
Summary
Cancer cells reprogram metabolism for growth and spread. Targeting these metabolic shifts offers new strategies against breast cancer metastasis.
Area of Science:
- Oncology
- Cancer Metabolism
- Molecular Biology
Background:
- Cancer is driven by genetic and metabolic changes.
- Metabolic reprogramming is a hallmark of cancer, influencing breast cancer.
- Distinct metabolic profiles exist across breast cancer subtypes.
Purpose of the Study:
- To explore metabolic alterations in breast cancer metastasis.
- To identify therapeutic targets for disrupting cancer spread.
- To understand the role of metabolism in cancer progression.
Main Methods:
- Review of recent evidence on cancer metabolism.
- Analysis of metabolic phenotypes in breast cancer.
- Investigation of metabolic interactions within the tumor microenvironment.
Main Results:
- Cancer cells exhibit altered nutrient uptake and utilization.
- Metabolic reprogramming supports cancer cell survival and metastasis.
- The tumor microenvironment significantly influences cancer metabolism.
Conclusions:
- Metabolic dysregulation is crucial for breast cancer metastasis.
- Targeting metabolic adaptations may inhibit cancer spread.
- Understanding cancer metabolism offers therapeutic opportunities.
Keywords:
Breast cancerCirculating tumor cells (CTCs)Epithelial-mesenchymal transition (EMT)MetabolismMetastasisMetastatic colonizationMore Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

